![Barry Quart](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barry Quart
Algemeen Directeur bij
CONNECT BIOPHARMA HOLDINGS LIMITED
Vermogen: 1 M $ op 31-05-2026
Profiel
Barry D.
Quart was the founder of Ardea Biosciences, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2013.
Current jobs include Chief Executive Officer & Director at Connect Biopharma Holdings Ltd. starting in 2024; Director at NeuroGenetic Pharmaceuticals, Inc.; Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; and Independent Director at Kiniksa Pharmaceuticals International Plc starting in 2024.
Former jobs include Chairman & Chief Executive Officer at Heron Therapeutics, Inc. from 2020 to 2023; Director at Trimeris, Inc. from 2007 to 2011; Director, SVP-Global Research & Development at Pfizer (La Jolla); Independent Director at Synageva BioPharma Corp.
from 2012 to 2015; President-Research & Development at Agouron Pharmaceuticals LLC; Senior VP-Pfizer Global Research & Development at Pfizer Inc.; and President at Napo Pharmaceuticals, Inc. from 2002 to 2006.
Education includes a doctorate from The University of California, San Francisco.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,03% | 29-05-2026 | 15.345 ( 0,03% ) | 742 391 $ | 31-05-2026 |
| 16-03-2026 | 224.034 ( 0,4% ) | 557 845 $ | 31-05-2026 |
Actieve functies van Barry Quart
| Bedrijven | Functie | Begin |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Algemeen Directeur | 12-06-2024 |
NeuroGenetic Pharmaceuticals, Inc.
 NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Directeur/Bestuurslid | - |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Directeur/Bestuurslid | 01-10-2015 |
Kiniksa Pharmaceuticals Corp.
 Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Directeur/Bestuurslid | - |
Eerdere bekende functies van Barry Quart
| Bedrijven | Functie | Einde |
|---|---|---|
| HERON THERAPEUTICS, INC. | Algemeen Directeur | 03-04-2023 |
| SYNAGEVA BIOPHARMA CORP | Directeur/Bestuurslid | 22-06-2015 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Oprichter | 01-05-2013 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Directeur/Bestuurslid | 04-11-2011 |
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | President | 01-12-2006 |
Opleiding van Barry Quart
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
60
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Heron Therapeutics, Inc.
 Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and distributes therapeutic products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for viral diseases | Health Technology |
Napo Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets human gastrointestinal pharmaceuticals | Health Technology |
NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the prevention of neurodegenerative conditions | Health Technology |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule therapeutics | Health Technology |
Pfizer (La Jolla)
 Pfizer (La Jolla) Miscellaneous Commercial ServicesCommercial Services Provides research services | Commercial Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Kiniksa Pharmaceuticals Corp.
Kiniksa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes therapeutic medicines for patients suffering from debilitating diseases | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
